Poland
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
361.41%
|
Dec. 31, 2023 | USD 1.01 | 1.23% |
|
Poland |
|
2 |
38.45%
|
Dec. 31, 2023 | USD 2.34 | 1.69% |
|
Poland |
|
3 |
36.20%
|
Dec. 31, 2023 | USD 11.11 | -3.75% |
|
Poland |
|
4 |
25.41%
|
Dec. 31, 2023 | USD 1.05 | -1.52% |
|
Poland |
|
5 |
24.17%
|
Dec. 31, 2023 | USD 0.77 | 0.43% |
|
Poland |
|
6 |
19.90%
|
Dec. 31, 2023 | USD 6.09 | -0.44% |
|
Poland |
|
7 |
7.02%
|
Dec. 31, 2023 | USD 2.77 | 1.63% |
|
Poland |
|
8 |
-172.95%
|
Dec. 31, 2023 | USD 7.78 | -9.75% |
|
Poland |
|
9 |
-490.60%
|
Dec. 31, 2023 | USD 10.54 | 0.97% |
|
Poland |
|
10 |
-833.38%
|
Dec. 31, 2023 | USD 9.29 | -3.28% |
|
Poland |
|
11 |
-2,100.89%
|
Dec. 31, 2023 | USD 1.85 | -0.17% |
|
Poland |
|
12 |
-3,342.44%
|
Dec. 31, 2023 | USD 40.10 | -0.57% |
|
Poland |
|
13 |
-27,449.47%
|
Dec. 31, 2023 | USD 3.73 | -0.03% |
|
Poland |
|
14 |
-389,809.76%
|
Dec. 31, 2023 | USD 0.79 | 1.05% |
|
Poland |
|
15 |
-775,600.00%
|
Dec. 31, 2023 | USD 1.74 | 1.31% |
|
Poland |
|
16 |
-16,413,896.00%
|
Dec. 31, 2023 | USD 2.23 | 1.07% |
|
Poland |
The Biotechnology company in Poland with the highest EBITDA Margin is Pharmena S.A. (Warsaw Stock Exchange: PHR.WA) at 361.41%.
The Biotechnology company in Poland with the lowest EBITDA Margin is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at -16,413,896.00%.
The top 10 Biotechnology companies in Poland by EBITDA Margin are Pharmena S.A., Mabion S.A., Selvita S.A., Synthaverse S.A., BIOTON S.A., Celon Pharma S.A., BioMaxima S.A., Ryvu Therapeutics S.A., Captor Therapeutics Spolka Akcyjna and Poltreg S.A..
The bottom 10 Biotechnology companies in Poland by EBITDA Margin are Molecure S.A., Genomtec S.A., NanoGroup S.A., Pure Biologics Spólka Akcyjna, Scope Fluidics S.A., Medinice S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, Ryvu Therapeutics S.A. and BioMaxima S.A..